Veronika Knorr1, Manfred Ogris, Ernst Wagner. 1. Pharmaceutical Biology-Biotechnology, Center for Drug Research and Center for NanoScience, Ludwig-Maximilians-Universität München, Munich, Germany.
Abstract
PURPOSE: Dynamic PEG-polycation copolymers that release PEG and degrade into small fragments after cell entry might present efficient and biocompatible gene carriers. METHODS: PEG-OEI-MK was synthesized by copolymerization of 5 kDa polyethyleneglycol (PEG) and 800 Da oligoethylenimines through acid-degradable acetone-bis-(N-maleimidoethyl)ketal linkers (MK). To evaluate any benefit of the reversible over stable linkage, also the corresponding pH-stable analog, PEG-OEI-BM, was synthesized via ether linkages. Luciferase and GFP expression plasmids were used for transfections, in vivo biocompatibility was evaluated by intravenous application of polymers in Balb/c mice. RESULTS: PEG-OEI-MK showed efficient DNA binding as analyzed by ethidium bromide exclusion, resulting in formation of polyplexes with sizes around 100 nm and surface charges of below 5 mV zeta potential. This surface shielding of PEG-OEI-MK polyplexes remained stable at neutral pH 7.4, while polyplexes deshielded and aggregated at pH 5 within 15-30 min. Cell culture experiments demonstrated reduced polymer toxicity compared to the non-PEGylated OEI-MK. Transfection experiments demonstrated reduced gene expression of PEG-OEI-BM compared with the non-PEGylated analog OEI-BM, whereas the pH-reversible polymer PEG-OEI-MK mediated a significant increased transfection efficiency over the non-PEGylated OEI-MK. CONCLUSIONS: PEG-OEI-MK mediated the highest gene transfer at lowest cytotoxicity levels and also best in vivo biocompatibility.
PURPOSE: Dynamic PEG-polycation copolymers that release PEG and degrade into small fragments after cell entry might present efficient and biocompatible gene carriers. METHODS:PEG-OEI-MK was synthesized by copolymerization of 5 kDa polyethyleneglycol (PEG) and 800 Da oligoethylenimines through acid-degradable acetone-bis-(N-maleimidoethyl)ketal linkers (MK). To evaluate any benefit of the reversible over stable linkage, also the corresponding pH-stable analog, PEG-OEI-BM, was synthesized via ether linkages. Luciferase and GFP expression plasmids were used for transfections, in vivo biocompatibility was evaluated by intravenous application of polymers in Balb/c mice. RESULTS:PEG-OEI-MK showed efficient DNA binding as analyzed by ethidium bromide exclusion, resulting in formation of polyplexes with sizes around 100 nm and surface charges of below 5 mV zeta potential. This surface shielding of PEG-OEI-MK polyplexes remained stable at neutral pH 7.4, while polyplexes deshielded and aggregated at pH 5 within 15-30 min. Cell culture experiments demonstrated reduced polymertoxicity compared to the non-PEGylated OEI-MK. Transfection experiments demonstrated reduced gene expression of PEG-OEI-BM compared with the non-PEGylated analog OEI-BM, whereas the pH-reversible polymerPEG-OEI-MK mediated a significant increased transfection efficiency over the non-PEGylated OEI-MK. CONCLUSIONS:PEG-OEI-MK mediated the highest gene transfer at lowest cytotoxicity levels and also best in vivo biocompatibility.
Authors: Ji Hoon Jeong; Lane V Christensen; James W Yockman; Zhiyuan Zhong; Johan F J Engbersen; Won Jong Kim; Jan Feijen; Sung Wan Kim Journal: Biomaterials Date: 2007-01-10 Impact factor: 12.479
Authors: P Erbacher; T Bettinger; P Belguise-Valladier; S Zou; J L Coll; J P Behr; J S Remy Journal: J Gene Med Date: 1999 May-Jun Impact factor: 4.565
Authors: Sabine Boeckle; Katharina von Gersdorff; Silke van der Piepen; Carsten Culmsee; Ernst Wagner; Manfred Ogris Journal: J Gene Med Date: 2004-10 Impact factor: 4.565
Authors: Pontus Lundberg; Bongjae F Lee; Sebastiaan A van den Berg; Eric D Pressly; Annabelle Lee; Craig J Hawker; Nathaniel A Lynd Journal: ACS Macro Lett Date: 2012-10-10 Impact factor: 6.903